Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Bayesian Analyses
Pharmacopsychiatry · 01.11.2025 · 58 (06) · 273-283
DOI: 10.1055/a-2590-3469 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Pharmacopsychiatry, erschienen am 01.11.2025. Verfasst von Ludovic C Dormegny-Jeanjean und 9 weiteren Autor:innen. Beteiligte Einrichtung: Non-Invasive neuroModulation Center of Strasbourg (CEMNIS), department of Psychiatry of Elderly and NeuroStimulation (PPANS), University Hospital of …. Hauptthemen laut MEDLINE: Antidepressive Agents, Blood Pressure, Depressive Disorder, Treatment-Resistant, Ketamine. Die Arbeit nennt 46 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Ketamine and esketamine (ESK) offer new treatment options for resistant depression. Unlike traditional antidepressants, they can be used in combination with non-selective monoamine oxidase inhibitors (NS-MAOI) without the risk of serotonergic syndrome. However, potential sympathomimetic synergy may lead to elevated blood pressure (BP). This series investigates whether cardiovascular parameters (heart rate, systolic [SP], and diastolic [DP] pressures) increase during ESK sessions and whether the ESK+NS-MAOI combination is associated with BP elevations. We collected cardiovascular parameters for ESK sessions conducted between 2018 and 2022. These parameters were measured at baseline and every 30 min for 2 h. Patients were categorized into two non-equivalent groups: those receiving ESK alone and those receiving ESK+NS-MAOI. A Bayesian random model was used to estimate the evolution of these parameters, while a Bayesian hierarchical model assessed factors contributing to BP elevation. ESK sessions (n=193), of which 116 involved NS-MAOI, were performed in 13 patients. SP, DP, and heart rate showed peak increases during sessions, but these changes were not clinically significant (SP+8.68 mmHg, DP+6.57 mmHg, and heart rate+3.5 bpm). No significant differences were found between the ESK-alone and ESK+NS-MAOI groups. The combination was not identified as a factor linked to BP elevations. These findings align with previous research on ketamine derivatives and suggest minimal peripheric sympathomimetic synergy with NS-MAOI. Bayesian models were used to account for biases intrinsically related to these ecological data and provide a foundation for future open adversarial collaborations. Registration NCT05530668
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Non-Invasive neuroModulation Center of Strasbourg (CEMNIS), department of Psychiatry of Elderly and NeuroStimulation (PPANS), University Hospital of Strasbourg, Strasbourg, France.
- Physiology and Functional Explorations Department, University Hospital of Strasbourg, Strasbourg, France.
- CNRS UMR 7357 ICube, FMTS, University of Strasbourg, Strasbourg, France.
- Pharmacy Department, University Hospital of Strasbourg, Strasbourg, France.
- EA 3072, "Mitochondria, Oxidative Stress and Muscle Protection", University of Strasbourg, Strasbourg, France.
- UR7296 "Laboratory of NeuroCardiovascular Pharmacology and Toxicology", University of Strasbourg, Strasbourg, France.
Zitieren
APA
Dormegny-Jeanjean, L. C., Lenoir, S., Humbert, I., Mainberger, O. A. E., Lozere, C., Meyer, C., Geny, B., Michel, B., Foucher, J. R., & de Crespin de Billy, C. (2025). Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Bayesian Analyses. Pharmacopsychiatry, 58(06), 273-283. https://doi.org/10.1055/a-2590-3469
Vancouver
Dormegny-Jeanjean LC, Lenoir S, Humbert I, Mainberger OAE, Lozere C, Meyer C, et al. Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Bayesian Analyses. Pharmacopsychiatry. 2025;58(06):273-283. doi:10.1055/a-2590-3469
BibTeX
@article{DormegnyJeanjean2025,
author = {Dormegny-Jeanjean, Ludovic C and Lenoir, Suzie and Humbert, Ilia and Mainberger, Olivier A E and Lozere, Coraline and Meyer, Camille and Geny, Bernard and Michel, Bruno and Foucher, Jack R and de Crespin de Billy, Clément},
title = {Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Bayesian Analyses},
journal = {Pharmacopsychiatry},
year = {2025},
volume = {58},
number = {06},
pages = {273--283},
doi = {10.1055/a-2590-3469}
}
EUVIMED